Zobrazeno 1 - 10
of 18
pro vyhledávání: '"D W, Schulz"'
Autor:
Desai Kishor A, B. K. Koe, D. W. Schulz, C. B. Fox, Macor John E, D. H. Blank, Anne W. Schmidt, L. A. Lebel, P. A. Seymour, Ronald J. Post
Publikováno v:
ChemInform. 27
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 294(2)
Corticotropin-releasing factor 1 (CRF(1)) receptor antagonists may represent a novel group of drugs for the pharmacotherapy of depression and/or anxiety disorders. We have investigated the behavioral, endocrine, and neurochemical effects of chronic a
Autor:
T F, Seeger, P A, Seymour, A W, Schmidt, S H, Zorn, D W, Schulz, L A, Lebel, S, McLean, V, Guanowsky, H R, Howard, J A, Lowe
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 275(1)
Ziprasidone (CP-88,059) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects in preclinical assays predictive of antipsychotic activity. Whereas the compound is a dopamine antagonist in vitro and in vivo, its
Autor:
J E, Macor, J, Blake, C B, Fox, C, Johnson, B K, Koe, L A, Lebel, J M, Morrone, K, Ryan, A W, Schmidt, D W, Schulz
Publikováno v:
Journal of medicinal chemistry. 35(23)
Autor:
J E, Macor, C A, Burkhart, J H, Heym, J L, Ives, L A, Lebel, M E, Newman, J A, Nielsen, K, Ryan, D W, Schulz, L K, Torgersen
Publikováno v:
Journal of medicinal chemistry. 33(8)
The synthesis and in vitro and in vivo characteristics of 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one (1, CP-93,129) are described. This rotationally restricted phenolic analogue of RU-24,969 is a potent (15 nM) and selective (200x vs t
Autor:
S J, Berger, G W, DeVries, J G, Carter, D W, Schulz, P N, Passonneau, O H, Lowry, J A, Ferrendelli
Publikováno v:
The Journal of biological chemistry. 255(7)
Frozen sections of retinas from rabbit (mostly rods), ground squirrel (mostly cones), and monkey (mixed rods and cones) were freeze dried, and samples from all the discrete layers analyzed for the enzymes which form cyclic GMP and subsequently conver
Publikováno v:
Advances in experimental medicine and biology. 204
Publikováno v:
Progress in brain research. 79
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 236(3)
SCH23390 is a dopamine antagonist which has a high affinity for D1-like dopaminergic receptors. Receptor binding studies demonstrated significant levels of specific SCH23390 binding within nigral tissue. Therefore, electrophysiological experiments we
Publikováno v:
Advances in neurology. 15